
Experts agree that the expansion of telehealth was one of the most significant positive outcomes of the COVID-19 pandemic.
Dan Nardi, MS, is the CEO of Reimagine Care, the nation's leading on-demand cancer care provider. It partners with health systems to deliver personalized, home-centered treatment through AI-enabled support, evidence-based pathways, and 24/7 oncology expertise.
Experts agree that the expansion of telehealth was one of the most significant positive outcomes of the COVID-19 pandemic.
The experts emphasized that these shortcomings must be addressed to be better prepared for future public health crises.
Experts agree that telemedicine continues to majorly impact health care post pandemic.
Dan Nardi, MS, CEO of Reimagine Care, claims that on-demand cancer treatment via telehealth is the future of oncology care delivery.
The long-term impact of disruptions in oncology care during the COVID-19 pandemic will become more apparent in the coming years, according to Dan Nardi, MS, of Reimagine Care.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.